FIMECS
Acquired創薬で新しい未来をつくるファイメクス株式会社
Japan · $10.3M raised
- Business Model
- B2B
- Website
- fimecs.com
- Total Funding
- $10.3M
- Last Round
- $10.3M Series BJan 2022
- Rounds
- 2
- Acquisition Date
- Feb 2024
About
UTokyo IPC life science portfolio company - drug discovery
Summary
FIMECS is a Biotech company based in Japan. It has raised $10.3M in total across 2 rounds, most recently a $10.3M Series B round in Jan 2022. Investors include Nissay Capital, Takeda (JP) and ANRI.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.